Simvastatin, baricitnib clinical trials

Precision medicine Adaptive Network platform Trial in Hypoxaemic acutE respiratory failuRe

This study looks at new ways to treat a serious lung condition called ARDS, which makes breathing very difficult. We're testing two medicines, simvastatin and baricitinib, in patients over 18 in intensive care, hoping to find better and faster treatments.